This inventor holds 5 USPTO granted patents. Top assignee: Kansas State University Research Foundation. Active years: 1998-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Los Angeles, CA (US) (2000 - 2006)
- Manhattan, KS (US) (1998 - 2018)
Company Filing History:
Years Active: 1998-2018
Title: Jishu Shi: Innovator in Vaccine Adjuvants and Peptide Research
Introduction
Jishu Shi is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of pharmaceutical and veterinary compositions, particularly in the development of vaccine adjuvants. With a total of 5 patents to his name, his work focuses on enhancing immune responses through innovative peptide-based solutions.
Latest Patents
One of Jishu Shi's latest patents involves the creation of vaccine adjuvants derived from self-assembling peptides. These pharmaceutical compositions are designed to treat or protect subjects from various conditions using peptide-based adjuvants. The adjuvants consist of a peptide that features a hydrophobic region, a turning region, and a hydrophilic region. Notably, the turning region includes specific amino acid residues, GSII (SEQ ID NO: 10). This innovative approach aims to immunopotentiate active agents by improving the immune response to them.
Another significant patent focuses on synthetic peptides that inhibit leukocyte superoxide anion production and attract leukocytes. This patent discloses methods for utilizing specific peptides, including the proline-arginine (PR)-rich antimicrobial peptide known as PR-39 and its truncated analogs. These peptides serve as medicaments that combat infections by drawing leukocytes to wound sites while minimizing tissue damage caused by excessive oxygen radicals produced by these leukocytes.
Career Highlights
Jishu Shi is affiliated with the Kansas State University Research Foundation, where he continues to advance his research in peptide technology and vaccine development. His work has garnered attention for its potential applications in improving health outcomes through innovative therapeutic strategies.
Collaborations
Some of Jishu Shi's notable coworkers include Frank Blecha and Christopher R. Ross. Their collaborative efforts contribute to the ongoing research and development in the field of peptide-based therapies.
Conclusion
Jishu Shi stands out as an influential inventor in the realm of vaccine adjuvants and peptide research. His innovative patents and contributions to the scientific community highlight the importance of advancing medical technologies for better health solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
